CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 1. A, the structure of Mdm2 and the position of the mutants used in this study are shown. B, Western blot analysis of Mdm2 and p53 protein levels after cotransfection into U2OS cells. Wild-type p53 was cotransfected with each of the indicated Mdm2 mutants and a plasmid expressing GFP to demonstrate equal transfection efficiencies. Arrows show Mdm2 proteins. C, Western blot analysis of p53 and Mdm2 levels after cotransfection of wild-type Mdm2 or the Mdm2 point mutant 464Ala with wild-type p53 into U2OS cells.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation